ImmuPharma PLC (IMM) - Total Liabilities

Latest as of June 2025: GBX1.24 Million GBX ≈ $151.37 USD

Based on the latest financial reports, ImmuPharma PLC (IMM) has total liabilities worth GBX1.24 Million GBX (≈ $151.37 USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of ImmuPharma PLC to assess how effectively this company generates cash.

ImmuPharma PLC - Total Liabilities Trend (2004–2024)

This chart illustrates how ImmuPharma PLC's total liabilities have evolved over time, based on quarterly financial data. Check ImmuPharma PLC asset resilience ratio to evaluate the company's liquid asset resilience ratio.

ImmuPharma PLC Competitors by Total Liabilities

The table below lists competitors of ImmuPharma PLC ranked by their total liabilities.

Company	Country	Total Liabilities
Kropz Plc LSE:KRPZ	UK	GBX89.51 Million
London Finance and Investment Group PLC LSE:LFI	UK	GBX257.00K
Parkmead Group PLC LSE:PMG	UK	GBX5.47 Million
BLOCKMATE VENTURES INC. F:8MH	Germany	€7.30 Million
Artisanal Spirits Company PLC LSE:ART	UK	GBX38.62 Million
Aquila Energy Efficiency Trust PLC LSE:AEET	UK	GBX892.00K
Eden Research plc LSE:EDEN	UK	GBX2.85 Million

Liability Composition Analysis (2004–2024)

This chart breaks down ImmuPharma PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ImmuPharma PLC (IMM) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.21	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.69	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.79	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how ImmuPharma PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for ImmuPharma PLC (2004–2024)

The table below shows the annual total liabilities of ImmuPharma PLC from 2004 to 2024.

Year	Total Liabilities	Change
2024-12-31	GBX1.52 Million ≈ $184.92	-8.72%
2023-12-31	GBX1.67 Million ≈ $202.60	+14.73%
2022-12-31	GBX1.45 Million ≈ $176.58	-8.39%
2021-12-31	GBX1.58 Million ≈ $192.76	+25.65%
2020-12-31	GBX1.26 Million ≈ $153.41	+137.07%
2019-12-31	GBX531.87K ≈ $64.71	-48.60%
2018-12-31	GBX1.03 Million ≈ $125.90	-28.28%
2017-12-31	GBX1.44 Million ≈ $175.54	+23.97%
2016-12-31	GBX1.16 Million ≈ $141.60	-23.57%
2015-12-31	GBX1.52 Million ≈ $185.26	+11.39%
2014-12-31	GBX1.37 Million ≈ $166.32	-24.12%
2013-12-31	GBX1.80 Million ≈ $219.19	-13.87%
2012-12-31	GBX2.09 Million ≈ $254.48	+17.97%
2011-12-31	GBX1.77 Million ≈ $215.72	+12.07%
2010-12-31	GBX1.58 Million ≈ $192.48	-75.88%
2009-12-31	GBX6.56 Million ≈ $798.16	+203.42%
2008-12-31	GBX2.16 Million ≈ $263.05	+105.90%
2007-12-31	GBX1.05 Million ≈ $127.75	-27.03%
2006-12-31	GBX1.44 Million ≈ $175.08	+28.14%
2006-03-31	GBX1.12 Million ≈ $136.64	+7921.43%
2005-03-31	GBX14.00K ≈ $1.70	+600.00%
2004-03-31	GBX2.00K ≈ $0.24	--

About ImmuPharma PLC

LSE:IMM UK Biotechnology

Market Cap

$263.02K

GBX2.16 Billion GBX

Market Cap Rank

#30753 Global

#990 in UK

Share Price

GBX4.30

Change (1 day)

+7.50%

52-Week Range

GBX1.50 - GBX17.60

All Time High

GBX190.00